कृपया अन्य खोज का प्रयास करें
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. It has a research collaboration with TRx Biosciences Limited for the formulation development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist product; and Medtronic plc to develop a novel, high concentration, thermostable insulin for use by Medtronic's Diabetes business in a next-generation implantable pump. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Susan Day Lowther | 61 | 2019 | CFO, Company Secretary & Director |
Andrew John McGlashan Richards | 61 | 2016 | Non-Executive Chairman |
Sarah Jennifer Howell | 45 | 2011 | CEO & Director |
Christine Helen Soden | 63 | 2021 | Independent Non-Executive Director |
Eda Cengiz | - | 2017 | Member of Global Diabetes Scientific Advisory Board |
Mohammad Sohail Fazeli | 56 | 2017 | Independent Non-Executive Director |
Jeremy Lewis Morgan | 57 | - | Independent Non-Executive Director |
Alan Edward Smith | 75 | - | Non-Executive Director |
Bruce Buckingham | - | 2017 | Member of Global Diabetes Scientific Advisory Board |
Thomas R. Pieber | - | 2017 | Member of Global Diabetes Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है